H-1152 dihydrochloride 是一种膜通透的，选择性的 ROCK 抑制剂，Ki 值为 1.6 nM，对 ROCK2 的 IC50 值为 12 nM。
CAS：871543-07-6
分子式：C16H23Cl2N3O2S
分子量：392.34
纯度：98%
存储：Store at -20°C

Background:

H-1152 dihydrochloride is a membrane-permeable and selective ROCK inhibitor, with a Ki value of 1.6 nM, and an IC50 value of 12 nM for ROCK2. ROCKII|12 nM (IC50)|CaMKII|0.18 μM (IC50)|PKG|0.36 μM (IC50)|AuroraA|0.745 μM (IC50)|PKA|3.03 μM (IC50)|Src|3.06 μM (IC50)|PKC|5.68 μM (IC50)|Abl|7.77 μM (IC50)|MKK4|16.9 μM (IC50)|MLCK|28.3 μM (IC50)|EGFR|50 μM (IC50)|GSK3α|60.7 μM (IC50)|AMPK|100 μM (IC50)|P38α|100 μM (IC50)

H-1152 dihydrochloride is an inhibitor of Rho-kinase, with an IC50 of 12 nM for ROCK2. H-1152 (H-1152P) also shows less inhibitory activities against CaMKII, PKG, AuroraA, PKA, Src, PKC, MLCK, Abl, EGFR, MKK4, GSK3α, AMPK, and P38α, with IC50s of 0.180, 0.360, 0.745, 3.03, 3.06, 5.68, 28.3, 7.77, 50.0, 16.9, 60.7, 100, and 100 μM, respectively[1]. H-1152 potently inhibits Rho kinase, with a Ki of 1.6 nM, and slightly suppresses PKA, PKC and MLCK, with Kis of 0.63, 9.27, and 10.1 μM, respectively. H-1152 (0.1-10 µM) highly inhibits MARCKS phosphorylation, with an IC50 value of 2.5 µM in LPA-treated cells, but shows no such obvious effects in PDBu-treated cells[2]. H-1152 (0.5-10 μM) cuases no decreased neuronal survival. H-1152 (1, 5 or 10 μM) also exerts no alterations in the ratios of different neuronal morphologies. Furthermore, H-1152 (10 μM) increases neurite length in both BMP4 and LIF cultures[3].

[1]. Tamura M, et al. Development of specific Rho-kinase inhibitors and their clinical application. Biochim Biophys Acta. 2005 Dec 30;1754(1-2):245-52. Epub 2005 Sep 12. [2]. Ikenoya M, et al. Inhibition of rho-kinase-induced myristoylated alanine-rich C kinase substrate (MARCKS) phosphorylation in human neuronal cells by H-1152, a novel and specific Rho-kinase inhibitor. J Neurochem. 2002 Apr;81(1):9-16. [3]. Lie M, et al. Accelerated neurite growth from spiral ganglion neurons exposed to the Rho kinase inhibitor H-1152. Neuroscience. 2010 Aug 25;169(2):855-62.